نتائج البحث - Kanwal P. Raghav
- يعرض 1 - 2 نتائج من 2
-
1
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations حسب Sarina A. Piha-Paul, Chieh Tseng, Cheuk Hong Leung, Ying Yuan, Daniel D. Karp, Vivek Subbiah, David Hong, Siqing Fu, Aung Naing, Jordi Rodon, Milind Javle, Jaffer A. Ajani, Kanwal P. Raghav, Neeta Somaiah, Gordon B. Mills, Apostolia M. Tsimberidou, Xiaofeng Zheng, Ken Chen, Funda Meric-Bernstam
الحاوية / القاعدة npj Precision Oncology (2024-07-01)احصل على النص الكامل
مقال -
2
Phase 2 study of pembrolizumab in patients with advanced rare cancers حسب Vivek Subbiah, Linghua Wang, Sara Ahmed, Michael Frumovitz, Jing Gong, Chantale Bernatchez, Siqing Fu, Aung Naing, Funda Meric-Bernstam, Shubham Pant, Nizar Tannir, Renata Ferrarotto, Joud Hajjar, Shi-Ming Tu, Mingxuan Xu, Anas Alshawa, Bettzy Stephen, Matthew Campbell, David S Hong, Sarina A Piha-Paul, Jordi Rodon Ahnert, Apostolia M Tsimberidou, Daniel D Karp, Timothy A Yap, Rivka R Colen, Vinod Ravi, Camilo Jimenez, Kanwal P Raghav, Gauri R Varadhachary, Ecaterina E Ileana Dumbrava, Sarjeel H Sabir, Saria Khan, Jeane M Painter, Abulrahman Abonofal, Richard M Simon
الحاوية / القاعدة Journal for ImmunoTherapy of Cancer (2020-05-01)احصل على النص الكامل
مقال
